middle.news

How Is Telix Driving 63% Revenue Growth Amid SEC Scrutiny?

9:08pm on Friday 29th of August, 2025 AEST Healthcare
Read Story

How Is Telix Driving 63% Revenue Growth Amid SEC Scrutiny?

9:08pm on Friday 29th of August, 2025 AEST
Key Points
  • 63% revenue growth to $390.4 million driven by Illuccix and RLS acquisition
  • Net loss after tax of $2.3 million due to higher operating expenses and finance costs
  • R&D investment increased to $81.6 million focusing on late-stage therapeutic assets
  • Completed key acquisitions including RLS Radiopharmacies and ImaginAb
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about TLX
OPEN ARTICLE